At Evotec, we help turn promising oncology innovations into clinical realities through expert-driven biomarker strategies. Our translational biomarker services support both standalone and integrated drug discovery projects, enabling accurate target identification, patient stratification, and therapeutic response monitoring.

With more than 80 dedicated experts and access to over 1,000 patient samples annually across 20+ oncology indications, we deliver end-to-end solutions—from biomarker discovery and validation to clinical assay deployment under GxP or non-GxP conditions. Leveraging advanced platforms in genomics, proteomics, cytometry, and histology, as well as strategic access to human samples, we ensure that every biomarker strategy is robust, scalable, and clinically relevant.

Whether you’re optimizing early-phase development or advancing through clinical trials, Evotec is your trusted partner in accelerating precision oncology.